explore -WSS

explore

author：comprehensive 2025-09-14 21:59:02 - browse：49385

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Global cancer cases to surge 77% by 2050, WHO report says

focus

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Editas, Vertex strike deal on CRISPR

Cano Health’s bankruptcy is a warning for Medicare Advantage

Three trends to watch in biotech in 2024

Carvykti CAR

Medicare drug price negotiation hasn't dried up venture capital

focus

explore

focus

Cancer drug shortages should be causing more outrage

Grail spinoff by Illumina should end disastrous merger attempt

Apple is now the first public company to be valued at $3 trillion

Keeping primary care docs in field isn't impossible, says AAFP CEO

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why health records don't always know when patients are dead

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why Novartis is going to walk from its acquisition of MorphoSys

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: The latest on Moderna, Apellis, and Merck

knowledge

Violet CEO on training clinicians to promote more inclusive care

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Bernie brings in new pharma CEOs to talk drug prices

Medicare Advantage beneficiaries sue Humana over algorithm use

Medicare Advantage plans can’t deny care with AI, CMS warns

entertainment

Wikipedia

focus

explore